KRT19 and breast cancer: Interestingly, Epi2 also expressed Krt19, which has been shown to reprogram CSCs in breast cancer to a more-drug-sensitive state.[50] Due to the specific enrichment patterns and patient composition of these clusters, they likely represent specific tumor-clone evolving populations.